The patient was on drugs Inj. CEFTAZIDIME 1g BD from POD:0-5; Inj.
TEICOPLANIN 200mg BD from POD:1-11; Inj. PANTOPRAZOLE 40mg BD POD: 0-4
which was changed to Tab. PANTOPRAZOLE 40mg OD BBF POD:5-13, Inj.
METHYLPREDNISOLONE 125mg BD POD:1-11; Inj. ONDANSETRON and TRAMADOL were
given as STAT drugs on POD:0,1; Tab. MYCOPHENOLIC ACID 360mg BD as
immunosuppressants from POD:0-13 ; Tab. TACROLIMUS 1mg BD as
immunosuppressants from POD:2-13; Tab. AMLODIPINE POD:3-7 for his
elevated Blood Pressure (BP) levels; Syrup GELUSIL 2 tsp TID POD:0-5 for
his constipation; Tab. SULFAMETHOXAZOLE+TRIMETHOPRIM OD as prophylactic
anti-bacterial from POD:5-11 which was withheld due to hyperkalemia;
Tab. VALGANCICLOVIR 450mg OD as prophylactic anti-viral from POD:5-13;
Tab. FLUCONAZOLE 150mg Alternate date as prophylactic anti-fungal from
POD:5-13; Syrup POTKLOR 10ml TID POD:6-11; K-BIND Sachets POD:11-13 for
hyperkalemia; Tab. AMOXICILLIN+POTASSIUM CLAVULANATE 625mg BD as
antibiotic from POD:10-13; Tab. PREDNISOLONE 10mg BD as
immunosuppressant from POD:11-13.
The patient was discharged on 7 February 2022 POD-13 and was advised to
review after one week (on 15 February 2022) in the OPD with repeat Renal
Function Tests. The medications advised were Tab. WYSOLONE 10mg BD; Tab.
TACROLIMUS 2mg BD; Tab. MYCOPHENOLIC ACID 360mg BD; Tab. PANTOPRAZOLE
40mg OD BBF; Tab. AMOXICILLIN+POTASSIUM CLAVULANATE 625mg BD (3 days);
K-BIND Sachets BD (until next follow-up).